Loading page...

Back
RFA-NS-26-001 Open
Send to:
National Institutes of Health United States

Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

Open

Overview

Funding agency
National Institutes of Health HHS-NIH11
Reference
RFA-NS-26-001
Region
United States
Source
Grants.gov (US Federal)

Description

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications for the conduct of scientific research utilizing data from expanded access (EA) for investigational drugs or biological products as described in section 561 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb). These applications will target intermediate size populations of patients living with…

Sign up to view full grant details

Create a free account to unlock the complete grant description, funding details, eligibility criteria, and application links.

Full description Funding amounts & eligibility Application links & deadlines Save & track grants

Related grants

Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (ESI) National Institutes of Health Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional) National Institutes of Health Research Grants in Clinical Informatics (R01 Clinical Trial Optional) National Institutes of Health

Send to CRM

CRM Integration Required

To send grants directly to your CRM, you need to connect your CRM system to TenderPipe first.

Configure CRM in Settings

Email Grant

Scroll to Top